Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
VLX1570 suppresses the viability of BCWM
which is currently under clinical trial for Alzheimer's disease
CAS Number: 1375603-36-3
22 mg/mL (4
Rapastinel Catalog No.:M13065-2 VLX1570 suppresses the viability ofRapastinel (GLYX 13) is an N methyl D aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist. Target: NMDA Rapastinel is a robust cognitive enhancer and facilitates hippocampal long term potentiation (LTP) of synaptic transmission in slices. Product information CAS Number: 117928 94 6 Molecular Weight: 413. 47 Formula: C18H31N5O6 Synonym: GLYX 13 Chemical Name: (2S,3R) 2 {[(2S) 1 [(2S) 1 [(2S,3R) 2 amino 3
US$ 68.00
US$ 85.00
US$ 140.00
US$ 74.00
US$ 195.00
US$ 95.00
US$ 76.00
US$ 29.90
US$ 29.90
US$ 24.95